Background
Despite large improvements in the diagnosis and treatment of infective endocarditis (IE), this disease remains severe: the inhospital mortality rate is about 20%, the 5-year mortality rate is approximately 40%, and more than 50% of patients have to be operated on during the initial phase [1] . While recommendations on prophylaxis against IE have existed for more than 50 years [2] , they have changed dramatically over the past few years. In 2002, the French were the first to make drastic modifications [3] [4] [5] [6] . In 2004, the European Society of Cardiology (ESC) [7] and the British Cardiac Society (BCS) [8] made virtually no changes to their existing recommendations, whereas the British Society for Antimicrobial Chemotherapy (BSAC) issued recommendations in 2006 that were similar to the French recommendations [9] . In 2007, the recommendations of the American Heart Association (AHA) took the same direction [10] . In 2008, the recommendations by the British National Institute for Health and Clinical Excellence (NICE) went even further [11] . This paper aims to review the evolution of the recommendations over the past few years and the reasons behind the changes that have been made.
2002: major change to French recommendations
In 2002, the group that organized the consensus conference on prophylaxis against IE in 1992 decided to review the literature published in the intervening 10 years and to consider the opportunity for making a change to the recommendations. Three papers were issued: an argument that included a thorough review of the literature, and a 'long version' and a 'short version' of the recommendations [3] [4] [5] . The recommendations were also published in the archives des maladies du coeur et des vaisseaux [6] and an English version also exists [12] . The following points were made:
• IE remains a severe disease; in the mouth, bacteraemia that can induce IE is more likely to be caused by a daily crossing of bacteria from mouth to blood than by occasional buccodental care; Table 1 Heart diseases with infective endocarditis risk; French recommendations [3] . In case of infection Antibiotic prophylaxis: non-adapted Mandatory curative antibiotic therapy a Endodontic care in group A patients must be exceptional and can be undertaken only after checking the tooth's vitality with adequate tests, using a sterile operating area, in a single session, making sure that the entire pulp canal is accessible. This treatment must, therefore, be reserved for monoradicular teeth, and perhaps for the first premolar tooth if both pulp canals are accessible. b Separating roots should be avoided, if possible, and performed only in the absence of any periodontal damage.
• there is no scientific proof of the efficacy or inefficacy of antibiotic prophylaxis; • in France, antibiotic prophylaxis before buccodental care is performed in fewer than 50% of patients with at risk heart disease;
• even if the efficacy of antibiotic prophylaxis was 100%, widespread use would prevent only a very small number of cases of IE; • in France, there is a worrying increase in bacteria that are not completely sensitive to antibiotics.
Consequently, the working group made the following suggestions: to maintain the principle of antibiotic prophylaxis when performing at risk procedures in patients with at risk heart diseases but to limit its use to cases in which the ratio of individual benefit to individual and collective risk is the highest.
The recommendations of the working group do not override the physician's evaluation of individual risk for a given patient.
Definition of at risk groups
Two groups of patients are defined: group A, high risk (high incidence and severity [morbidity, mortality] of IE) and group B, lesser risk (lesser incidence and severity of IE) ( Table 1) .
Compared with the global population, there is no increased risk of IE with other cardiac conditions, i.e., atrial septal defect, pacemaker (but the implantation of the pacemaker requires antibiotic prophylaxis), coronary angioplasty with or without implantation of an endoprosthesis, dilated cardiomyopathy without significant mitral regurgitation, isolated mitral stenosis and minimal valvular regurgitation detected only by Doppler echocardiography.
Importance of hygiene measures
General hygiene measures are of fundamental importance; the aim is to decrease the risk of bacteraemia, whatever its origin, especially bacteraemia caused by bacteria that have a cardiac tropism. The hygiene measures include prevention and treatment of infectious foci: strict and permanent buccodental and cutaneous hygiene to prevent any rupture of the cutaneous and mucosal barriers, disinfection of wounds, curative antibiotic treatment of any infectious foci, strict compliance with asepsis when performing operations associated with a risk of infection, and eradication or decrease of the bacterial inoculum in cases of chronic skin carriage (renal dialysis). The buccodental state must be surveyed systematically at least twice a year in patients with a heart disease associated with an IE risk.
Any procedure that leads to a mucosal or cutaneous wound must be prevented. Piercing is strictly contraindicated in at risk patients. Acupuncture should be used only after informing the patient of the possible risk of IE and with adequate clinical surveillance after the treatment. Infusion catheters should be limited to cases in which they are mandatory, especially in at risk patients; they should be replaced systematically every 3-4 days, peripheral rather than central catheters should be used, and the infusion needle entry site should be surveyed closely.
Buccodental procedures
In patients from groups A and B, a chlorhexidine mouthwash is recommended for 30 seconds before dental care and buccodental care should be given in as few sessions as possible. If care requires several sessions, these must be at least 10 days apart, if possible. Contraindicated procedures, and procedures for which antibiotic prophylaxis is recommended, optional or not recommended, are presented in Table 2 . In group B patients, antibiotic prophylaxis is optional; the decision should be made by the physician managing the patient, taking into account the nature of care and the patient's state. Factors for this choice are listed in Table 3 . Whatever the choice, it must be made after informing the patient and obtaining their consent to the offered strategy, which must be written down on a follow-up file given to each patient. The patient should know that if they experience fever or symptoms, especially in the month after dental care, they must consult a physician as soon as possible, before starting any antibiotic treatment, and inform the physician of the previous dental care so that blood cultures can be done before initiating antibiotic treatment.
Non-buccodental procedures
Contraindicated procedures, and procedures for which antibiotic prophylaxis is recommended, optional or not recommended, are presented in Table 4 .
Modalities of antibiotic prophylaxis
These are given in Tables 5-7 .
2004: status quo for the ESC and the BCS
The 2004 ESC recommendations [7] cite the French recommendations issued in 1985 [13] , but do not cite those published in 2002, despite the existence of an English version. The 2004 recommendations are similar to the previous recommendations.
The 2004 recommendations of the BCS and the Royal College of Physicians [8, 14, 15] resemble the ESC recommendations. Paediatric dose, amoxicillin 50 mg/kg intravenously in the hour before the procedure and 25 mg/kg orally 6 hours later; vancomycin 20 mg/kg (maximum 1 g); no official approval for antibiotic prophylaxis with teicoplanine in children.
2006: major change to the BSAC recommendations
The 2006 BSAC recommendations [9] are similar to the French recommendations. The working group reiterates that there is no proof of the efficacy of antibiotic prophylaxis but takes into account the fact that clinicians would be reluctant to accept a recommendation for not providing prophylaxis. The British limit antibiotic prophylaxis to patients who are at particularly high risk for IE (French group A). As in the French recommendations, there are tables listing the procedures and detailing whether antibiotic prophylaxis is recommended or not. The working group adds an appendix for patients, which dentists may use when they explain the changes to the recommendations: An editorial presented these recommendations as a 'radical step' [16] and there have been diametrically opposed views [17] [18] [19] [20] , with the risk of lack of understanding by practitioners and patients being stressed [21] . The British Congenital Cardiac Association and the BCS indicated their displeasure [18] . For all these reasons, NICE was petitioned to help to resolve 'the current situation' (see below) [16, 18, 22] .
Prevention of Infective Endocarditis Guidelines Information for Patients and Parents. A BSAC group of experts has spent a lot of time carefully looking at whether dental treatment procedures are a possible cause of IE [sometimes called bacterial endocarditis], which is

2007: major change to the American recommendations
The recommendations of the AHA cite the French and BSAC recommendations and are endorsed by the American Dental Association, the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society [10] .
These recommendations are the 10th version to be issued by the AHA. The 1st version was published in 1955 [2] . The fundamental underlying principles that drove the formulation of the AHA guidelines and the 9 previous AHA documents were as follows: IE is an uncommon but life-threatening disease and prevention is preferable to treatment of established infection; certain underlying cardiac conditions predispose to IE; bacteraemia with organisms known to cause IE occurs usually in association with invasive dental, gastrointestinal or genitourinary tract procedures; antimicrobial prophylaxis is proven to be effective for prevention of experimental IE in animals; antimicrobial prophylaxis is thought to be effective in humans for prevention of IE associated with dental, gastrointestinal or genitourinary tract procedures.
The 2007 working group believes that the first 4 underlying principles are valid and have not changed in the past 30 years, but that the validity of the fifth principle must be questioned.
The primary reasons for the revision of the IE prophylaxis guidelines are as follows:
• IE is much more likely to result from frequent exposure to random bacteraemia associated with daily activities than from bacteraemia caused by a dental, gastrointestinal tract or genitourinary tract procedure; prophylaxis may prevent an exceedingly small number of cases of IE, if any, in individuals who undergo a dental, gastrointestinal tract or genitourinary tract procedure; • the risk of antibiotic-associated adverse events exceeds the benefit, if any, of prophylactic antibiotic therapy; • maintenance of optimal oral health and hygiene may reduce the incidence of bacteraemia from daily activities and is more important than prophylactic antibiotics for a dental procedure to reduce the risk of IE.
Rationale for and against IE prophylaxis
Most published studies have focused on dental procedures as a cause of IE.
Frequency, nature, magnitude and duration of bacteraemia associated with a dental procedure
Transient bacteraemia occurs frequently with manipulation of the teeth and periodontal tissues, but there is a wide variation in the frequency of bacteraemia resulting from dental procedures. Transient bacteraemia also occurs frequently during routine daily activities unrelated to dental procedures, such as brushing teeth and chewing food. The frequency of bacteraemia from routine daily activities is far greater than that associated with a dental procedure. There are more than 700 species of bacteria in the mouth. Approximately 30% of the flora are streptococci, predominantly of the viridans group.
The magnitude of bacteraemia resulting from a dental procedure is relatively low (<10 4 colony-forming units of bacteria per milliliter), similar to that resulting from routine daily activities, and is less than that used to cause experimental IE in animals (10 6 -10 8 colony-forming units of bacteria per milliliter). Although the infective dose required to cause IE in humans is unknown, the number of microorganisms present in blood after a dental procedure or associated with daily activities is low. Cases of IE caused by oral bacteria probably result from exposure to low inocula of bacteria in the bloodstream that result from routine daily activities and not from a dental procedure. Additionally, most patients with IE have not had a dental procedure within the 2 weeks before the onset of symptoms of IE.
There may not be a clinically significant difference in the frequency, nature, magnitude and duration of bacteraemia associated with a dental procedure compared with the frequency, nature, magnitude and duration of bacteraemia resulting from routine daily activities.
Impact of dental disease, oral hygiene and type of dental procedure on bacteraemia
It is assumed that a relationship exists between poor oral hygiene, the extent of dental and periodontal disease, the type of dental procedure, and the frequency, nature, magnitude and duration of bacteraemia, but the presumed relationship is controversial. Nevertheless, available evidence supports an emphasis on maintaining good oral hygiene and eradicating dental disease to decrease the frequency of bacteraemia from routine daily activities. Tooth extraction is thought to be the dental procedure most likely to cause bacteraemia. However, numerous other dental procedures have been reported to be associated with a risk of bacteraemia that is similar to that resulting from tooth extraction.
Impact of antibiotics on bacteraemia from a dental procedure
The ability of antibiotic therapy to prevent or reduce the frequency, magnitude or duration of bacteraemia associated with a dental procedure is controversial. Some studies reported that antibiotics administered before a dental procedure reduced the frequency, nature and/or duration of bacteraemia, whereas others did not.
Cumulative risk over time of bacteraemia from routine daily activities compared with from a dental procedure
Guntheroth estimated a cumulative exposure to bacteraemia of 5370 minutes over a 1-month period resulting from random bacteraemia from chewing food and oral hygiene measures, such as brushing teeth [23] . Roberts estimated that brushing teeth twice daily for 1 year had a 154,000 times greater risk of exposure to bacteraemia than that resulting from a single tooth extraction [24] . The cumulative exposure to bacteraemia from routine daily activities during 1 year may be as high as 5.6 million times greater than that resulting from a single tooth extraction [24] .
Results of clinical studies of prophylaxis against IE for dental procedures
A prospective randomized trial has not been done. Data from case-control studies are limited by the low incidence of IE, the wide variation in the types and severity of underlying cardiac conditions, and the large variety of invasive dental procedures and dental disease states [25] [26] [27] [28] [29] . In the studies by van der Meer et al., dental and other procedures caused only a small fraction of cases of IE and prophylaxis would prevent only a small number of cases even if it were 100% effective [28, 29] . Strom et al. concluded that dental treatment was not a risk factor for IE even in patients with valvular heart disease [27] . In a recent French study, the risk of IE from a dental procedure was estimated at 1 in 46,000, falling to 1 in 150,000 with prior antibiotic treatment. The authors conclude that 'a huge number of prophylaxis doses would be necessary to prevent a very low number of cases' [30] .
Absolute risk of IE resulting from a dental procedure
If dental treatment causes 1% of all cases of viridans group streptococcal IE annually, the overall risk in the general population is estimated to be as low as one case of IE per 14 million dental procedures. The estimated absolute risk rates for IE from a dental procedure in patients with underlying cardiac conditions are as follows:
• mitral valve prolapse, 1 per 1.1 million procedures;
• congenital heart disease (CHD), 1 per 475,000 procedures;
• presence of a prosthetic cardiac valve, 1 per 114,000 procedures; • previous IE, 1 per 95,000 procedures.
It is likely that the number of cases of IE that result from a dental procedure is exceedingly small. Therefore the number of cases that could be prevented by antibiotic prophylaxis, even if 100% effective, is similarly small.
Cardiac diseases and IE
The American working group considered 3 distinct issues:
• the underlying cardiac conditions that have the highest predisposition to the acquisition of IE over a lifetime; • the underlying cardiac conditions associated with the highest risk of adverse outcome from IE; • whether the recommendations for IE prophylaxis should be based on either or both of these two conditions.
For 3 cardiac conditions -prosthetic cardiac valve, previous IE and cyanotic CHD (Table 8 ) -both risk of IE and risk of adverse outcome from IE are increased. Antibiotic prophylaxis is recommended before dental care in patients with these cardiac conditions. There are no more recommendations for other patients (French group B), in whom risk of IE is increased but the risk of adverse outcome is not increased.
Antibiotic prophylaxis
An antibiotic for prophylaxis should be administered in a single dose before the procedure. If, inadvertently, the antibiotic is not administered before the procedure, it may be administered up to 2 hours after the procedure.
Dental procedures for which IE prophylaxis is reasonable are all dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa. The recommended antibiotic is amoxicillin, 2 g, 30 to 60 minutes before the dental care. If the oral route cannot be used, ampicillin, cefazolin or ceftriaxone can be Table 8 Cardiac conditions associated with the highest risk of adverse outcome from endocarditis for which prophylaxis with dental procedures is reasonable; American recommendations [10] .
Prosthetic cardiac valve or prosthetic material used for cardiac valve repair Previous infective endocarditis CHD a Unrepaired cyanotic CHD, including palliative shunts and conduits Congenital heart defect completely repaired with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure b Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibit endothelialization) Cardiac transplantation recipients who develop cardiac valvulopathy CHD: congenital heart disease. a Other than for the conditions listed above, antibiotic prophylaxis is no longer recommended for any other form of CHD. b Prophylaxis is reasonable because endothelialization of prosthetic material occurs within 6 months after the procedure. Additionally, approximately one third of patients with mitral valve prolapse without mitral regurgitation at rest may have exerciseinduced mitral regurgitation. Some patients may exhibit mitral regurgitation at rest on one occasion and not on another. There are no data available to address this latter issue, and at present, the decision must be left to clinical judgment, taking into account the nature of the invasive procedure, the previous history of endocarditis, and the presence or absence of valve thickening and/or redundancy. Class I: benefit »> risk; procedure/treatment SHOULD be performed/administered. Class IIa: benefit » risk; additional studies with focused objectives needed; IT IS REASONABLE to perform procedure/administer treatment. Class III: risk ≥ benefit; procedure/treatment should NOT be performed/administered AS IT IS NOT HELPFUL AND MAY BE HARMFUL. Level of evidence B: limited populations evaluated; data derived from a single randomized trial or non-randomized studies.
Level of evidence C: very limited populations evaluated; only consensus opinion of experts, case studies, or standard of care. used. For individuals who are allergic to penicillins or amoxicillin, the use of cephalexin or another first-generation oral cephalosporin, clindamycin, azithromycin or clarithromycin is recommended. Antibiotic prophylaxis is reasonable before an invasive procedure of the respiratory tract that involves incision or biopsy of the respiratory mucosa, such as tonsillectomy and adenoidectomy. Antibiotic prophylaxis is not recommended for bronchoscopy unless the procedure involves incision of the respiratory tract mucosa.
The administration of prophylactic antibiotics solely to prevent IE is not recommended for patients who undergo genitourinary or gastrointestinal tract procedures, including diagnostic oesophagogastroduodenoscopy or colonoscopy.
In August 2008, the American College of Cardiology (ACC) and the AHA published a 'focused update' on IE prophylaxis [31] . Previously, the writing of recommendations could last 3 years. Since 2006, the ACC and the AHA have settled a faster update procedure. New data are reviewed twice a year. However, the text does not cite the recommendations by NICE that were published in April 2008. Differences between the 2006 recommendations on valvular heart disease [32] and the 2007 recommendations on prevention of IE [10] are presented in Table 9 .
2008: major change to the British recommendations
Very recently, NICE, an independent organization in charge of issuing recommendations on health, published recommendations on the prevention of IE [11] The main differences between the 4 recommendation texts [3, [9] [10] [11] are presented in Table 10 [33]. With these last recommendations, 'the loop is looped' in 2002, the French proposed that antibiotic prophylaxis before a procedure should be optional in patients at risk but not at very high risk of IE (group B). Whereas the ESC and the BCS did not change their previous recommendations in 2004, the British infectious disease specialists went a step further than the French in 2006, i.e., no more prophylaxis in group B patients. An additional step was taken by the ACC and the AHA in 2007, i.e. no more prophylaxis before genitourinary or gastrointestinal procedures in group A patients. The final step was taken by NICE in 2008, i.e. no antibiotic prophylaxis at all! There already are indignant reactions in the literature and the debate is just beginning. However, it must be stressed that all these recommendation texts are based on very complete and thorough literature reviews. The recommendation not to give any antibiotic prophylaxis against IE in patients at risk for IE is not absurd as there is no proof of its efficacy.
The ESC is revising its recommendations on IE and the new recommendations are expected in 2009. The French Society of Cardiology, the French Society of Infectious Diseases (SPILF: Société de pathologie infectieuse de langue française) and other societies concerned by IE will then have to endorse or not endorse these recommendations.
Until then, what to do? The French recommendations do not differ greatly from the American and the 2006 British recommendations. Perhaps the 2008 NICE guidance goes too far. We would advise adhering to our 2002 guidelines while waiting for the French revised guidelines, which will be published in 2009 or 2010.
The different countries must monitor the incidence of IE in order to detect any increase and must verify whether an increase is due to less use of antibiotic prophylaxis, as some Californian investigators did recently in a very preliminary study [34] .
